GE HealthCare agrees to acquire full ownership of Nihon Medi-Physics
NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and neurology.
GE Healthcare to buy radiopharmaceutical firm Nihon Medi-Physics
GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.
GE HealthCare to fully own Nihon Medi-Physics
GE HealthCare will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese radiopharmaceutical company.
GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics from Sumitomo Chemical
GE HealthCare (NASDAQ:GEHC) has agreed to acquire the remaining 50% stake in Nihon Medi-Physics (NMP) from Sumitomo Chemical (OTCPK:SOMMY), aiming to assume full ownership of the Japanese radiopharmaceutical company.
GE HealthCare to take over Japanese radiopharmaceutical venture
Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of Nihon Medi-Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents.
GE HealthCare To Buy Out Japan's Nihon Medi-Physics; Terms Not Disclsoed
GE HealthCare Technologies Inc. (GEHC) announced its agreement to acquire the remaining 50% stake in Nihon Medi-Physics Co., Ltd or
GE Healthcare to acquire full stake in Nihon Medi-Physics
GE HealthCare has owned half of Nihon Medi-Physics since 2004, when former parent company General Electric obtained the stake as part of its acquisition of drugmaker Amersham.
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics (NMP), a leading radiopharmaceutical company in Japan, from Sumitomo Chemical
GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics
GE HealthCare (GEHC) has agreed to acquire full ownership of Nihon Medi-Physics, by purchasing from Sumitomo Chemical the 50% stake it does not
Crain's Chicago Business2d
GE HealthCare fully acquires Japanese pharma company
The Chicago-based medical device and technology giant plans to purchase the remaining 50% stake in Nihon Medi-Physics.
InnovationRx: FDA Issues New Guidance For AI In Medical Devices
This week, the FDA issued recommendations for streamlining the clearance process for AI-powered medical devices. The memo announcing this change recognizes that the utilization of AI in devices “is an ...